BA
MRNS

BlackRock Advisors’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

BlackRock Advisors’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-8,007
Closed -$41K – 3757
2016
Q2 		$41K Hold
8,007
– – ﹤0.01% 3273
2016
Q1 		$172K Sell
8,007
-150
-2% -$3.18K ﹤0.01% 2638
2015
Q4 		$249K Buy
+8,157
New +$239K ﹤0.01% 2453

Other funds holding MRNS

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

BlackRock Advisors's MRNS Position: Q3 2016 in Review

BlackRock Advisors sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q3 2016, closing a stake of 8,007 shares — an estimated $41K sold.

BlackRock Advisors first reported a position in MRNS in Q4 2015 and held it in 3 quarters. The position peaked at $249K in Q4 2015. 26 funds tracked by Wall St. Rank hold MRNS as of Q3 2016.

  • BlackRock Advisors reported no remaining Marinus Pharmaceuticals, Inc position as of Q3 2016 after selling out during the quarter.
  • BlackRock Advisors sold 8,007 Marinus Pharmaceuticals, Inc shares in Q3 2016, an estimated $41K.
  • BlackRock Advisors first reported a position in Marinus Pharmaceuticals, Inc in Q4 2015 and held it in 3 quarters.
  • BlackRock Advisors's Marinus Pharmaceuticals, Inc position peaked at $249K in Q4 2015.
  • 26 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q3 2016.

Based on BlackRock Advisors's 13F filing for Q3 2016, filed 8 Nov 2016.